Narek G. Karapetyan

Narek G. Karapetyan

Auto-generated profile, based on publicly available information

Narek G. Karapetyan

A.V. Vishnevsky National Medical Research Center of Surgery

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2019 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
BAB. G. Alekyan
B. G. Alekyan
АПА. В. Покровский
А. В. Покровский
NKN. G. Karapetyan
N. G. Karapetyan
АRА. Sh. Revishvili
А. Sh. Revishvili
The treatment of coronary artery disease (CAD) in patients with combined pathology of peripheral arteries who are to perform endovascular or surgical interventions is a difficult task. The most important issues are the adequate diagnostics of artery systems’ lesions, determining the most optimal strategy and stages of treatment. This makes a multidisciplinary approach with the involvement of various specialists the most optimal.Aim. Based on multidisciplinary approach, to determine the prevalence of CAD and treatment strategy in patients with lesions of the aorta and peripheral arteries.8Material and methods. The study included 693 patients with pathology of the aorta and peripheral arteries: 171 (32,5%) were female, and 522 (75,3%) were male. The age of patients ranged from 29 to 93 years, an average — 67,2+8,8 years. Also 32,5% of patients (n=223) were older than 71 years. Cardiac complaints were present only in 203 (29,3%) patients, while 490 (70,7%) were asymptomatic. The majority of 693 patients had an isolated lesion of the internal carotid artery (ICA) (n=196, 28,3%), a combined lesion of the ICA and lower limb arteries (n=93, 13,4%), a combined lesion of the iliac and superficial femoral arteries (n=70, 10,1%) and femoral arteries lesions (n=60, 8,6%).Results. Finally, 554 (79,9%) of 693 patients had lesions of at least one coronary artery more than 50%, while 368 (66,4%) of them were clinically asymptomatic. By the decision of the multidisciplinary heart team, 316 (57,0%) patients underwent myocardial revascularization operations: 21 (6,7%) — coronary artery bypass grafting and 295 (50,3%) — percutaneous coronary intervention. Surgical and endovascular operations for pathology of the aorta and peripheral arteries were performed in 486 (70,1%) of 693 patients. Unlike with 260 (53,5%) patients, in 226 (46,5%) patients, in addition to vascular surgery, myocardial revascularization was performed. As a result of 923 (564 endovascular and 359 surgical) operations performed in 580 patients at the hospital stage, 3 (0,51%) of them had a fatal outcome. In other 2 (0,56%) cases, there was stroke: in one case after ICA prosthetics, in the other case — thrombosis of the ICA after the carotid endarterectomy. Acute myocardial infarction at the hospital stage was not detected in any of the patients.Conclusion. In 79,9% of patients with atherosclerosis of the aorta and peripheral arteries, at least one coronary artery lesion of more than 50% is detected. In 66,4% of patients with pathology of the aorta and peripheral arteries and with lesions of the coronary arteries of more than 50%, there are no cardiac complaints. In 45,6% of patients hospitalized with a diagnosis of atherosclerotic lesions of the aorta and peripheral arteries, myocardial revascularization is required. A multidisciplinary approach is an effective and safe treatment strategy for patients with pathology of the aorta and peripheral arteries of atherosclerotic origin and concomitant CAD.

30 June 2022 in Patologiya krovoobrashcheniya i kardiokhirurgiya
Verified
Journal Article
Open access
PDF file
BAB.G. Alekyan
B.G. Alekyan
DRD.V. Ruchkin
D.V. Ruchkin
NKN.G. Karapetyan
N.G. Karapetyan
НИН. Л. Иродова
Н. Л. Иродова
NMN.N. Meleshenko
N.N. Meleshenko
ARA.SH. Revishvili
A.SH. Revishvili
Aortic valve stenosis and bleeding gastric cancer are formidable diseases characterized by high mortality. For a long time, the gold standard for treating patients with aortic stenosis has been open-heart surgery — aortic valve replacement. However, the endovascular operation that appeared in 2002 — transcatheter aortic valve implantation (TAVI) has become the standard of care for patients with high surgical risk. Gastric cancer is one of the major severe oncological diseases in which surgery is the only way to cure. The combination of these two diseases significantly worsens the prognosis and is a difficult clinical task for choosing the optimal tactics for treating a patient. Given the lack of developed standards for the treatment of multimorbid patients, the treatment plan is determined by an interdisciplinary consultation. But with a combination of these diseases, there is no generally accepted approach in the known recommendations. The purpose of this report is to present a clinical case of a patient with critical aortic stenosis, concomitant severe coronary artery disease, and bleeding stomach cancer, who underwent a successful one-stage operation — percutaneous coronary intervention, TAVI and open gastrectomy with Roux-loop reconstruction with one anesthetic aid by the decision of a multidisciplinary team. The patient was discharged in a satisfactory condition. In the late follow-up period, angina pectoris returned with restenosis of the stent in the anterior interventricular branch (LAD), which required repeated intervention in the form of LAD restenting with a good clinical result. A hybrid approach in the treatment of patients with critical aortic valve stenosis in combination with coronary artery disease and bleeding gastric cancer can be accepted as one of the possible strategies, but further research is needed in this direction. Received 15 October 2021. Revised 20 January 2022. Accepted 31 January 2022. Informed consent: The patient’s informed consent to use the records for medical purposes is obtained. Funding: The study did not have sponsorship. Conflict of interest: Authors declare no conflict of interest. Contribution of the authorsLiterature review: N.L. Irodova, L.G. GeletsyanDrafting the article: N.G. Karapetyan, N.N. MeleshenkoCritical revision of the article: B.G. Alekyan, A.Sh. RevishviliSurgical treatment: B.G. Alekyan, D.V. Ruchkin, N.G. Karapetyan, N.N. MeleshenkoFinal approval of the version to be published: B.G. Alekyan, D.V. Ruchkin, N.G. Karapetyan, N.L. Irodova, N.N. Meleshenko, L.G. Geletsyan, A.Sh. Revishvili

30 September 2019 in Russian Cardiology Bulletin
Verified
Journal Article
Closed access
BAB.G. Alekyan
B.G. Alekyan
NKN.G. Karapetyan
N.G. Karapetyan
VKV.V. Kravchenko
V.V. Kravchenko
ARA.Sh. Revishvili
A.Sh. Revishvili
С момента своего внедрения в клиническую практику чрескожные коронарные вмешательства (ЧКВ) постепенно стали методом выбора при лечении пациентов с локальными и несложными поражениями венечных артерий, резистентных к оптимальной медикаментозной терапии. Несмотря на это, использование ЧКВ для лечения пациентов с тяжелыми формами поражений коронарных артерий является предметом разночтений и споров и в настоящее время. В эпоху стентов с лекарственным антипролиферативным покрытием одним из наиболее важных и значимых исследований эффективности ЧКВ и коронарного шунтирования является, бесспорно, исследование SYNTAX (Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery согласованность ЧКВ с имплантацией стентов TAXUS и кардиохирургией). Полученные в ходе данного исследования результаты легли в основу рекомендаций по реваску1 ляризации миокарда Европейского общества кардиологов (ЕОК) 2014 и 2018 гг. Однако на данный момент имеются крайне важные и принципиальные несоответствия между современной клинической практикой и рандомизированным исследованием SYNTAX. Наибо1 лее существенным недостатком шкалы риска SYNTAX считается отсутствие индивидуализированного подхода при принятии решения о выборе метода реваскуляризации миокарда в силу отсутствия в ней клинических переменных. В данной статье будет рассмотрена новая шкала риска SYNTAX Score II (SS II) как более точный инструмент принятия решения в работе сердечной команды .Since its introduction into clinical practice, percutaneous coronary interventions (PCI) have gradually become the method of choice for treating patients with local and uncomplicated lesions of the coronary arteries that are resistant to optimal medicamental therapy. Despite this, the use of PCI for the treatment of patients with coronary artery disease carts is a matter of discrepancies and disputes even today. In the era of drug1elongated antiproliferative stents, one of the most important and significant studies of the efficacy of PCI and coronary shunting (CS) is undoubtedly the SYNTAX study (Synergy between TAXUS and Cardiac Surgery implantation of TAXUS and Cardiac Surgery). The results of this study formed the basis for the latest recommendations on myocardial revascularization of the European Society of Cardiology (EOC) 2014 and beyond 2018. However, at the moment there are extremely important and fundamental inconsistencies between modern clinical practice and the randomized SYNTAX study. The most significant drawback of the SYNTAX risk scale is the lack of an individualized approach when deciding on the choice of myocardial revascularization method due to the absence of clinical variables in it. This article will look at the new Syntax Score II risk scale as a more accurate decision1making tool in the work of the heart team.Since its introduction into clinical practice, percutaneous coronary interventions (PCI) have gradually become the method of choice for treating patients with local and uncomplicated lesions of the coronary arteries that are resistant to optimal medicamental therapy. Despite this, the use of PCI for the treatment of patients with coronary artery disease carts is a matter of discrepancies and disputes even today. In the era of drug1elongated antiproliferative stents, one of the most important and significant studies of the efficacy of PCI and coronary shunting (CS) is undoubtedly the SYNTAX study (Synergy between TAXUS and Cardiac Surgery implantation of TAXUS and Cardiac Surgery). The results of this study formed the basis for the latest recommendations on myocardial revascularization of the European Society of Cardiology (EOC) 2014 and beyond 2018. However, at the moment there are extremely important and fundamental inconsistencies between modern clinical practice and the randomized SYNTAX study. The most significant drawback of the SYNTAX risk scale is the lack of an individualized approach when deciding on the choice of myocardial revascularization method due to the absence of clinical variables in it. This article will look at the new Syntax Score II risk scale as a more accurate decision1making tool in the work of the heart team.

1 January 2022 in Russian Cardiology Bulletin
Verified
Journal Article
Closed access
BAB.G. Alekyan
B.G. Alekyan
NKN.G. Karapetyan
N.G. Karapetyan
ACA.V. Chupin
A.V. Chupin
AZA.E. Zotikov
A.E. Zotikov
AVA.B. Varava
A.B. Varava
ANA.M. Norvardyan
A.M. Norvardyan
ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить отдаленные результаты двух стратегий лечения пациентов с КИНК в сочетании с ИБС. МАТЕРИАЛ И МЕТОДЫ Проведено одноцентровое ретроспективное исследование, включающее 102 пациента с КИНК в сочетании с ИБС, которым выполнялись вмешательства на обоих артериальных бассейнах с применением рентгенэндоваскулярных и хирургических технологий. Решение о методе и этапности реваскуляризации артерий принималось на заседании консилиума «сердечно-сосудистой команды». В зависимости от выбранной стратегии реваскуляризации обоих артериальных бассейнов больные были распределены на две группы: 1-я группа — рентгенэндоваскулярное лечение (этапное ЧКВ и ангиопластика артерий нижних конечностей, n=53; 50,3%); 2-я группа — комбинированное лечение (этапное ЧКВ в сочетании с открытой хирургией артерий нижних конечностей, n=49; 48,0%). Отдаленные результаты лечения пациентов в сроке от 7 до 51 мес (медиана 31,5 мес) изучены у 85 (85%) из 100 выписанных больных на основании повторных госпитализаций (13,0%), амбулаторных осмотров (34,2%), анализа анкетных данных и опроса по телефону (52,8%). РЕЗУЛЬТАТЫ Суммарная общая отдаленная летальность составила 14,1% (в 1-й группе — 13,6%, в 2-й группе — 14,6%; p=0,89). Суммарная кардиоваскулярная смертность имела показатель 7,0% (в 1-й группе — 6,8%, во 2-й группе — 7,3%; p=0,92). Суммарная смертность от других не сердечно-сосудистых причин — 7,0% (в 1-й группе — 6,8%, во 2-й группе — 7,3%; p=0,92). Частота инсультов в двух группах — 3,5% (в 1-й группе — 4,5%, во 2-й группе — 2,4%; p=0,59). Частота рецидива симптомов стенокардии в группе 1-й — 2,3%, во 2-й группе рецидивы не зафиксированы. Суммарная частота рецидива ишемии нижних конечностей — 7,0% (в 1-й группе — 9,0%, во 2-й группе — 5,0%; p=0,44). Суммарная частота ампутаций нижних конечностей — 3,5% (в 1-й группе — 4,5%, во 2-й группе — 2,4%; p=0,59). Нелетальных инфарктов миокарда не выявлено ни в одной из групп. ВЫВОДЫ 1. В отдаленном периоде наблюдения больных с КИНК и ИБС не отмечено достоверной разницы в результатах рентгенэндоваскулярного (1-я группа) и комбинированного методов лечения (2-я группа) по таким показателям, как сердечно-сосудистые осложнения и неблагоприятные события на артериях нижних конечностей (p>0,5). 2. В отдаленные сроки наблюдения суммарная общая летальность составила 14,1%, сердечно-сосудистая — 7,0%. Частота инсультов — 3,5%. Нелетальных инфарктов миокарда не выявлено ни в одной из групп. 3. Обе стратегии лечения больных с КИНК в сочетании с ИБС показывают высокую безопасность и клиническую эффективность на госпитальном и отдаленном периодах наблюдения и могут широко применяться в повседневной клинической практике.

11 May 2022 in Complex Issues of Cardiovascular Diseases
Verified
Journal Article
Open access
PDF file
BAB. G. Alekyan
B. G. Alekyan
NKN. G. Karapetyan
N. G. Karapetyan
DKD. O. Kishmiryan
D. O. Kishmiryan
ARA. Sh. Revishvili
A. Sh. Revishvili
Treatment of patients with multivessel coronary artery disease is percutaneous coronary intervention or coronary artery bypass grafting according to current European and American guidelines. Depending on the anatomical complexity of the coronary artery lesion, one of the methods is chosen, with usage of a risk scale based on the SYNTAX study. However, Syntax score is actively discussed as not an optimal risk scale, because of unmatched with modern clinical possibilities This article presents current, different opinions on anatomical and clino-anatomical risk scores, which allows to choose the optimal method of revascularization for patients with three-vessel disease and/or left main coronary artery lesions.

28 February 2022 in Kardiologiia
Verified
Journal Article
Closed access
PDF file
BAB. G. Alekyan
B. G. Alekyan
APA. V. Pokrovskiy
A. V. Pokrovskiy
NKN. G. Karapetyan
N. G. Karapetyan
ACA. V. Chupin
A. V. Chupin
AVA. B. Varava
A. B. Varava
MSM. A. Sedgaryan
M. A. Sedgaryan
Aim      To compare in-hospital outcomes (severe cardiovascular complications, CVC) in patients with IIB stage chronic lower limb ischemia (CLLI) in combination with ischemic heart disease (IHD) in the following groups: stepwise percutaneous coronary intervention (PCI) and stenting and angioplasty of lower limb arteries (LLA) (group 1) and combination treatment, including PCI and open surgery on LLA (group 2). Material and methods  Since 2019, the A.V. Vishnevsky National Medical Research Center of Surgery has performed a retrospective study that includes patients with stage IIB CLLI in combination with IHD. Patients were divided into 2 groups: group 1 (n=46), stepwise X-ray endovascular treatment (PCI and stenting and angioplasty of LLA); group 2 (n=46), stepwise combination treatment (PCI and open surgery on LLA). The endpoint included severe CVCs (death, acute myocardial infarction, acute cerebrovascular disease) and severe complications in the LLA area (stent thrombosis, repeated intervention on LLA, amputation). Results In 198 surgeries, none of 92 patients had severe CVC, and no fatal outcomes were observed. In group 2, there was one (2.1 %) severe complication on LLA during the early postoperative period, for which a successful additional intervention was performed. Conclusion      Individualized approach to care of each patient with LLA pathology in combination with IHD helps avoiding severe CVCs at the hospital stage. It was shown that X-ray endovascular and combination treatments are safe and effective in the absence of fatal outcomes and acute disorders of coronary circulation at the hospital stage.